PROCEPT BioRobotics Announces FDA Clearance of the HYDROS™ Robotic System, the Next-Generation, AI-Powered Platform for Aquablation® Therapy - PROCEPT BioRobotics ( NASDAQ:PRCT )

4 weeks ago

SAN JOSE, Calif., Aug. 21, 2024 ( GLOBE NEWSWIRE ) -- PROCEPT BioRobotics® Corporation PRCT ( the "Company" ) , a surgical robotics company focused on advancing patient care by developing transformative solutions in urology, today announced FDA 510 ( k ) clearance of its next-generation ...

Ticker	Sentiment	Impact
PRCT	Somewhat Bullish	24 %